Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
1 The LEADER trial (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome ResultsA Long-Term Evaluation), a large double-blind, placebo-controlled trial, recently demonstrated that liraglutide added to standard therapy for a relatively short period of time (3.5-5 years) had a significant reduction in cardiovas-cular events and mortality compared to placebo in high-risk patients (hazard ratio [HR], 0.87
The back of the main shelf is most stable
Karakasis, Paschalis, et al
Multiple forms of hypogonadism of central, peripheral or combined origin in males with Prader-Willi syndrome
US$ 26.24
US$ 27.03
US$ 24.12
US$ 20.40
